Literature DB >> 21786198

Early calcium dysregulation in Alzheimer's disease: setting the stage for synaptic dysfunction.

Shreaya Chakroborty1, Grace E Stutzmann.   

Abstract

Alzheimer's disease (AD) is an irreversible and progressive neurodegenerative disorder with no known cure or clear understanding of the mechanisms involved in the disease process. Amyloid plaques, neurofibrillary tangles and neuronal loss, though characteristic of AD, are late stage markers whose impact on the most devastating aspect of AD, namely memory loss and cognitive deficits, are still unclear. Recent studies demonstrate that structural and functional breakdown of synapses may be the underlying factor in AD-linked cognitive decline. One common element that presents with several features of AD is disrupted neuronal calcium signaling. Increased intracellular calcium levels are functionally linked to presenilin mutations, ApoE4 expression, amyloid plaques, tau tangles and synaptic dysfunction. In this review, we discuss the role of AD-linked calcium signaling alterations in neurons and how this may be linked to synaptic dysfunctions at both early and late stages of the disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21786198     DOI: 10.1007/s11427-011-4205-7

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   6.038


  26 in total

1.  Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.

Authors:  Qing Yu; Fang Du; Justin T Douglas; Haiyang Yu; Shirley ShiDu Yan; Shi Fang Yan
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

2.  Soluble forms of tau are toxic in Alzheimer's disease.

Authors:  Katherine J Kopeikina; Bradley T Hyman; Tara L Spires-Jones
Journal:  Transl Neurosci       Date:  2012-09       Impact factor: 1.757

3.  Nitric oxide signaling is recruited as a compensatory mechanism for sustaining synaptic plasticity in Alzheimer's disease mice.

Authors:  Shreaya Chakroborty; Joyce Kim; Corinne Schneider; Anthony R West; Grace E Stutzmann
Journal:  J Neurosci       Date:  2015-04-29       Impact factor: 6.167

Review 4.  Overlapped metabolic and therapeutic links between Alzheimer and diabetes.

Authors:  Waqar Ahmad
Journal:  Mol Neurobiol       Date:  2012-09-26       Impact factor: 5.590

5.  SOCE-mediated NFAT1-NOX2-NLRP1 inflammasome involves in lipopolysaccharide-induced neuronal damage and Aβ generation.

Authors:  Zhenghao Sun; Xuewang Li; Liu Yang; Xianan Dong; Yuli Han; Yan Li; Jing Luo; Weizu Li
Journal:  Mol Neurobiol       Date:  2022-03-14       Impact factor: 5.590

6.  Synaptic alterations in the rTg4510 mouse model of tauopathy.

Authors:  Katherine J Kopeikina; Manuela Polydoro; Hwan-Ching Tai; Erich Yaeger; George A Carlson; Rose Pitstick; Bradley T Hyman; Tara L Spires-Jones
Journal:  J Comp Neurol       Date:  2013-04-15       Impact factor: 3.215

7.  β amyloid peptide plaques fail to alter evoked neuronal calcium signals in APP/PS1 Alzheimer's disease mice.

Authors:  Clark A Briggs; Corinne Schneider; Jill C Richardson; Grace E Stutzmann
Journal:  Neurobiol Aging       Date:  2013-01-18       Impact factor: 4.673

8.  Dantrolene Ameliorates Impaired Neurogenesis and Synaptogenesis in Induced Pluripotent Stem Cell Lines Derived from Patients with Alzheimer's Disease.

Authors:  Yong Wang; Ge Liang; Shuqing Liang; Rachel Mund; Yun Shi; Huafeng Wei
Journal:  Anesthesiology       Date:  2020-05       Impact factor: 7.892

Review 9.  Emerging pathways driving early synaptic pathology in Alzheimer's disease.

Authors:  Clark A Briggs; Shreaya Chakroborty; Grace E Stutzmann
Journal:  Biochem Biophys Res Commun       Date:  2016-09-20       Impact factor: 3.575

Review 10.  The Mechanistic Role of Bridging Integrator 1 (BIN1) in Alzheimer's Disease.

Authors:  Peirong Gao; Lingqi Ye; Hongrong Cheng; Honglei Li
Journal:  Cell Mol Neurobiol       Date:  2020-07-27       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.